Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of BMS-986177 with Itraconazole or Diltiazem
NCT02807909Phase 1Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jul 2016
- Primary completion
- Aug 2016
- Modality
- Small Molecules
01
Overview
Phase 1, open-label trial of milvexian in thrombosis (2 arms), sponsored by Bristol Myers Squibb. Primary endpoints: Area under the concentration-time curve from time zero to the time of the last quantifiable concentration, Maximum observed concentration and 1 more. Started Jul 2016; status: completed.
02
Drugs
milvexian
03
Conditions
thrombosis
Beyond the preview
Go deeper on NCT02807909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02807909.